Learn / ZBIO
NASDAQ: ZBIOZenas BioPharma (ZBIO) stock, explained like you're 5
Zenas BioPharma trades on the Nasdaq under the ticker ZBIO. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.8 billion dollars.
- Ticker
- ZBIO
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 1.8 billion dollars
Is Zenas BioPharma a small, medium or large cap company?
No. Zenas BioPharma is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.8 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Zenas BioPharma makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves ZBIO stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- 74,900 stock awards for Zenas' new hires vest in four yearly installments (Stock Titan)
- Learn Why The Bull Case For Zenas BioPharma Stock Could Change Following Phase 3 Data (Simply Wall Street)
- H.C. Wainwright reiterates Zenas Biopharma stock rating at buy (Investing.com)
- $ZBIO stock is down 8% today. Here's what we see in our data. (Quiver Quantitative)
- POWL,NPB,ARE,PSNL,PBF,ZBIO,RCL,NRXS | Stock Prices | Quote Comparison (Yahoo! Finance Canada)
Follow ZBIO in your daily brief
Each trading day at 5 PM ET we post what happened to Zenas BioPharma and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow ZBIO
Questions about Zenas BioPharma stock
What does Zenas BioPharma do?
Zenas BioPharma trades on the Nasdaq under the ticker ZBIO. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.8 billion dollars.
What is the ticker symbol for Zenas BioPharma?
Zenas BioPharma trades under the ticker ZBIO on the Nasdaq.
What is Zenas BioPharma's market cap?
Zenas BioPharma is a small cap stock with a market cap of about 1.8 billion dollars.
How does Zenas BioPharma make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves ZBIO stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow ZBIO stock every day?
Add ZBIO to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.
